Sharechat Logo

Tower medical insurance purchase weighs on NIB earnings

Tuesday 27th August 2013

Text too small?

The purchase of Tower's New Zealand medical insurance unit weighed on health insurer NIB in 2013, however Australia's only listed insurer expects the purchase to help grow future earnings.

The former Tower business, now known as NIB New Zealand, contributed $8 million, or 8.7 percent to the Newcastle, New South Wales-based parent's pre-tax net underwriting profit in the year ended June 30, the company said. The group's full-year profit fell to A$67.2 million from A$67.6 million the year earlier because of one-time costs to acquire the New Zealand business.

NIB is expanding into new geographic markets such as New Zealand as well as targeting new areas of business such as international workers and students as growth slows in its core Australian resident health insurance business. NIB is betting on growth in New Zealand where only about 30 percent of people have health and medical insurance, compared to almost 50 percent in Australia.

"We plan a major investment in New Zealand during FY14 designed to unlock what will hopefully turn out to be significant latent demand," managing director Mark Fitzgibbon said in a statement. "It will take a little time and expense but I see our New Zealand business being a very significant contributor to our future earnings."

NIB paid $103 million for the Tower medical insurance unit in November, gaining New Zealand's second-largest health insurer with more than 75,000 policyholders and market share of about 14 percent.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors